Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Antineoplastic Combined Chemotherapy Protocols administration & dosage"" wg kryterium: Temat


Tytuł :
Evaluation of Two Dosing Regimens for Nivolumab in Combination With Ipilimumab in Patients With Advanced Melanoma:Results From the Phase IIIb/IV CheckMate 511 Trial
Autorzy :
Lebbé, Celeste
Meyer, Nicolas
Mortier, Laurent
Marquez-Rodas, Ivan
Robert, Caroline
Rutkowski, Piotr
Menzies, Alexander M
Eigentler, Thomas
Ascierto, Paolo A
Smylie, Michael
Schadendorf, Dirk
Ajaz, Mazhar
Svane, Inge Marie
Gonzalez, Rene
Rollin, Linda
Lord-Bessen, Jennifer
Saci, Abdel
Grigoryeva, Elena
Pigozzo, Jacopo
Pokaż więcej
Temat :
Adult
Aged
Aged, 80 and over
Antineoplastic Agents, Immunological/administration & dosage
Antineoplastic Combined Chemotherapy Protocols/administration & dosage
Disease Progression
Double-Blind Method
Drug Administration Schedule
Female
Humans
Ipilimumab/administration & dosage
Male
Melanoma/drug therapy
Middle Aged
Neoplasm Staging
Nivolumab/administration & dosage
Progression-Free Survival
Skin Neoplasms/drug therapy
Time Factors
Young Adult
Clinical Trial, Phase III
Clinical Trial, Phase IV
Comparative Study
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Źródło :
Lebbé, C, Meyer, N, Mortier, L, Marquez-Rodas, I, Robert, C, Rutkowski, P, Menzies, A M, Eigentler, T, Ascierto, P A, Smylie, M, Schadendorf, D, Ajaz, M, Svane, I M, Gonzalez, R, Rollin, L, Lord-Bessen, J, Saci, A, Grigoryeva, E & Pigozzo, J 2019, ' Evaluation of Two Dosing Regimens for Nivolumab in Combination With Ipilimumab in Patients With Advanced Melanoma : Results From the Phase IIIb/IV CheckMate 511 Trial ', Journal of Clinical Oncology, vol. 37, no. 11, pp. 867-875 . https://doi.org/10.1200/JCO.18.01998
Opis pliku :
application/pdf
Tytuł :
Do we make progress in elderly patients with metastatic colorectal cancer?
Autorzy :
Glimelius, Bengt
Pfeiffer, Per
Pokaż więcej
Temat :
Age Factors
Aged
Antineoplastic Combined Chemotherapy Protocols/administration & dosage
Clinical Trials as Topic
Colorectal Neoplasms/drug therapy
Dose-Response Relationship, Drug
Geriatric Assessment
Humans
Patient Selection
Referral and Consultation
Treatment Outcome
Źródło :
Glimelius, B & Pfeiffer, P 2018, ' Do we make progress in elderly patients with metastatic colorectal cancer? ', Acta Oncologica, vol. 57, no. 11, pp. 1422-1426 . https://doi.org/10.1080/0284186X.2018.1535189
Tytuł :
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET):5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
Autorzy :
Martin, Miguel
Holmes, Frankie A.
Ejlertsen, Bent
Delaloge, Suzette
Moy, Beverly
Iwata, Hiroji
von Minckwitz, Gunter
Chia, Stephen K.L.
Mansi, Janine
Barrios, Carlos H.
Gnant, Michael
Tomašević, Zorica
Denduluri, Neelima
Šeparović, Robert
Gokmen, Erhan
Bashford, Anna
Ruiz Borrego, Manuel
Kim, Sung Bae
Jakobsen, Erik Hugger
Ciceniene, Audrone
Inoue, Kenichi
Overkamp, Friedrich
Heijns, Joan B.
Armstrong, Anne C.
Link, John S.
Joy, Anil Abraham
Bryce, Richard
Wong, Alvin
Moran, Susan
Yao, Bin
Xu, Feng
Auerbach, Alan
Buyse, Marc
Chan, Arlene
Cold, Soeren
Pokaż więcej
Temat :
Administration, Oral
Adult
Antibodies, Monoclonal, Humanized/adverse effects
Antineoplastic Combined Chemotherapy Protocols/administration & dosage
Breast Neoplasms/drug therapy
Chemotherapy, Adjuvant
Disease-Free Survival
Dose-Response Relationship, Drug
Double-Blind Method
Drug Administration Schedule
Female
Follow-Up Studies
Humans
Japan
Kaplan-Meier Estimate
Mastectomy/methods
Middle Aged
Neoplasm Invasiveness/pathology
Neoplasm Staging
Proportional Hazards Models
Quinolines/administration & dosage
Receptor, ErbB-2/metabolism
Risk Assessment
Survival Analysis
Time Factors
Trastuzumab/administration & dosage
Treatment Outcome
Źródło :
ExteNET Study Group 2017, ' Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET) : 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial ', The Lancet Oncology, vol. 18, no. 12, pp. 1688-1700 . https://doi.org/10.1016/S1470-2045(17)30717-9
Tytuł :
First-line intra-arterial versus intravenous chemotherapy in unilateral sporadic group D retinoblastoma: evidence of better visual outcomes, ocular survival and shorter time to success with intra-arterial delivery from retrospective review of 20 years of treatment
Autorzy :
Munier, F.L.
Mosimann, P.
Puccinelli, F.
Gaillard, M.C.
Stathopoulos, C.
Houghton, S.
Bergin, C.
Beck-Popovic, M.
Pokaż więcej
Temat :
Clinical Science
Retina
Aftercare
Antineoplastic Combined Chemotherapy Protocols/administration & dosage
Carboplatin/administration & dosage
Child
Child, Preschool
Etoposide/administration & dosage
Humans
Infant
Infusions, Intra-Arterial
Infusions, Intravenous
Melphalan/administration & dosage
Retinal Neoplasms/drug therapy
Retinoblastoma/drug therapy
Retrospective Studies
Salvage Therapy/methods
Treatment Outcome
Vision Disorders/prevention & control
Child health (paediatrics)
Neoplasia
Treatment Medical
Źródło :
The British Journal of Ophthalmology
The British journal of ophthalmology, vol. 101, no. 8, pp. 1086-1093
Opis pliku :
application/pdf
Tytuł :
ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS)
Autorzy :
Reynolds, J V
Preston, S R
O'Neill, B
Baeksgaard, L
Griffin, S M
Mariette, C
Cuffe, S
Cunningham, M
Crosby, T
Parker, I
Hofland, K
Hanna, G
Svendsen, L B
Donohoe, C L
Muldoon, C
O'Toole, D
Johnson, C
Ravi, N
Jones, G
Corkhill, A K
Illsley, M
Mellor, J
Lee, K
Dib, M
Marchesin, V
Cunnane, M
Scott, K
Lawner, P
Warren, S
O'Reilly, S
O'Dowd, G
Leonard, G
Hennessy, B
Dermott, R Mc
Pokaż więcej
Temat :
Neoadjuvant chemoradiation therapy
Carboplatin/administration & dosage
Neoplasm Recurrence, Local/drug therapy
Paclitaxel/administration & dosage
Research Support, Non-U.S. Gov't
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Adenocarcinoma/drug therapy
Esophageal Neoplasms/drug therapy
Study Protocol
Female
Antineoplastic Combined Chemotherapy Protocols/administration & dosage
Esophagogastric Junction/drug effects
Aged
Oesophagogastric junction
Adenocarcinoma
Middle Aged
Neoadjuvant Therapy
Clinical Trial, Phase III
Randomized Controlled Trial
Neoadjuvant chemotherapy
Disease-Free Survival
RC254-282
Journal Article
Multicenter Study
Adult
Quality of Life
Oesophageal
Humans
Male
Źródło :
Reynolds, J V, Preston, S R, O'Neill, B, Baeksgaard, L, Griffin, S M, Mariette, C, Cuffe, S, Cunningham, M, Crosby, T, Parker, I, Hofland, K, Hanna, G, Svendsen, L B, Donohoe, C L, Muldoon, C, O'Toole, D, Johnson, C, Ravi, N, Jones, G, Corkhill, A K, Illsley, M, Mellor, J, Lee, K, Dib, M, Marchesin, V, Cunnane, M, Scott, K, Lawner, P, Warren, S, O'Reilly, S, O'Dowd, G, Leonard, G, Hennessy, B & Dermott, R M 2017, ' ICORG 10-14 : NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS) ', B M C Cancer, vol. 17, 401 . https://doi.org/10.1186/s12885-017-3386-2
BMC Cancer, Vol 17, Iss 1, Pp 1-10 (2017)
Opis pliku :
application/pdf; text
Tytuł :
The number of extranodal sites assessed by PET/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma:An international multicenter study of 1532 patients treated with chemoimmunotherapy
Autorzy :
El-Galaly, Tarec Christoffer
Villa, Diego
Michaelsen, Thomas Yssing
Hutchings, Martin
Mikhaeel, Nabegh George
Savage, Kerry J.
Sehn, Laurie H.
Barrington, Sally
Hansen, Jakob W.
Smith, Daniel
Rady, Kirsty
Mylam, Karen J.
Larsen, Thomas S.
Holmberg, Staffan
Juul, Maja B.
Cordua, Sabrina
Clausen, Michael R.
Jensen, Kristina B.
Johnsen, Hans E.
Seymour, John F.
Connors, Joseph M.
de Nully Brown, Peter
Bøgsted, Martin
Cheah, Chan Y.
Pokaż więcej
Temat :
CNS relapse
Retrospective Studies
Secondary CNS involvement
Prednisone/administration & dosage
PET/CT
diffuse large B-cell lymphoma
Immunotherapy/methods
Central Nervous System Neoplasms/diagnostic imaging
Vincristine/administration & dosage
Young Adult
CNS-IPI
Cyclophosphamide/administration & dosage
extra nodal
Combined Modality Therapy
Antineoplastic Combined Chemotherapy Protocols/administration & dosage
Rituximab
Risk Factors
PET/CT imaging
Aged
CNS prophylaxis
Middle Aged
Prognosis
Treatment Outcome
Lymphoma, Large B-Cell, Diffuse/diagnostic imaging
Positron Emission Tomography Computed Tomography
Doxorubicin/administration & dosage
Neoplasm Recurrence, Local/diagnostic imaging
Antibodies, Monoclonal, Murine-Derived/administration & dosage
Adolescent
Journal Article
Aged, 80 and over
Adult
Humans
Male
Źródło :
El-Galaly, T C, Villa, D, Michaelsen, T Y, Hutchings, M, Mikhaeel, N G, Savage, K J, Sehn, L H, Barrington, S, Hansen, J W, Smith, D, Rady, K, Juul Mylam, K, Larsen, T S, Holmberg, S, Juul, M B, Cordua, S, Clausen, M R, Jensen, K B, Johnsen, H E, Seymour, J F, Connors, J M, de Nully Brown, P, Bøgsted, M & Cheah, C Y 2017, ' The number of extranodal sites assessed by PET/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma : An international multicenter study of 1532 patients treated with chemoimmunotherapy ', European journal of cancer (Oxford, England : 1990), vol. 75, pp. 195-203 . https://doi.org/10.1016/j.ejca.2016.12.029
El-Galaly, T C, Villa, D, Michaelsen, T Y, Hutchings, M, Mikhaeel, N G, Savage, K J, Sehn, L H, Barrington, S, Hansen, J W, Smith, D, Rady, K, Juul Mylam, K, Larsen, T S, Holmberg, S, Juul, M B, Cordua, S, Clausen, M R, Buchardi Jensen, K, Johnsen, H E, Seymour, J F, Connors, J M, de Nully Brown, P, Bøgsted, M & Cheah, C Y 2017, ' The number of extranodal sites assessed by PET/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma : An international multicenter study of 1532 patients treated with chemoimmunotherapy ', European Journal of Cancer, vol. 75, pp. 195-203 . https://doi.org/10.1016/j.ejca.2016.12.029
El-Galaly, T C, Villa, D, Michaelsen, T Y, Hutchings, M, Mikhaeel, N G, Savage, K J, Sehn, L H, Barrington, S, Hansen, J W, Smith, D, Rady, K, Mylam, K J, Larsen, T S, Holmberg, S, Juul, M B, Cordua, S, Clausen, M R, Jensen, K B, Johnsen, H E, Seymour, J F, Connors, J M, de Nully Brown, P, Bøgsted, M & Cheah, C Y 2017, ' The number of extranodal sites assessed by PET/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma : An international multicenter study of 1532 patients treated with chemoimmunotherapy ' European Journal of Cancer, vol. 75, pp. 195-203 . https://doi.org/10.1016/j.ejca.2016.12.029
El-Galaly, T C, Villa, D, Michaelsen, T Y, Hutchings, M, Mikhaeel, N G, Savage, K J, Sehn, L H, Barrington, S, Hansen, J W, Smith, D, Rady, K, Mylam, K J, Larsen, T S, Holmberg, S, Juul, M B, Cordua, S, Clausen, M R, Jensen, K B, Johnsen, H E, Seymour, J F, Connors, J M, de Nully Brown, P, Bøgsted, M & Cheah, C Y 2017, ' The number of extranodal sites assessed by PET/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma : An international multicenter study of 1532 patients treated with chemoimmunotherapy ', European Journal of Cancer, vol. 75, pp. 195-203 . https://doi.org/10.1016/j.ejca.2016.12.029
Opis pliku :
application/pdf
Tytuł :
Clinical aspects and perspectives of erlotinib in the treatment of patients with biliary tract cancer
Autorzy :
Jensen, Lars Henrik
Pokaż więcej
Temat :
Anticancer treatment
Biliary tract cancer
Clinical value
Erlotinib
Molecularly targeted agents
Palliative care
Bevacizumab/administration & dosage
Humans
Erlotinib Hydrochloride/administration & dosage
Molecular Targeted Therapy
Disease-Free Survival
Protein Kinase Inhibitors/administration & dosage
Animals
Biliary Tract Neoplasms/drug therapy
Drug Design
Antineoplastic Combined Chemotherapy Protocols/administration & dosage
Źródło :
Jensen, L H 2016, ' Clinical aspects and perspectives of erlotinib in the treatment of patients with biliary tract cancer ', Expert Opinion on Investigational Drugs, vol. 25, no. 3, pp. 359-365 . https://doi.org/10.1517/13543784.2016.1142973
Tytuł :
Brazilian experience using high dose sequential chemotherapy followed by autologous hematopoietic stem cell transplantation for malignant lymphomas
Autorzy :
Duarte, Bruno Kosa Lino
Miranda, Eliana Cristina Martins
Nucci, Marcio
Vigorito, Afonso Celso
Penteado, Francisco José
Marques Jr, José Francisco Comenalli
Oliveira-Duarte, Gislaine Borba
Lorand-Metze, Irene Gyongyver Heidemarie
Pagnano, Katia Borgia
Delamain, Marcia Torresan
Baldissera, Renata
Valente, Isabella Salvetti
Souza, Carmino Antonio de
Pokaż więcej
Temat :
Lymphoma
Antineoplastic Combined Chemotherapy Protocols/administration & dosage
Original Article
hemic and lymphatic diseases
Lymphoma, non-Hodgkin
Cyclophosphamide/administration & Dosage
Cyclophosphamide/administration & dosage
Diseases of the blood and blood-forming organs
Antineoplastic Combined Chemotherapy Protocols
Hematopoietic stem cell transplantation
Hodgkin Disease/drug Therapy
Transplantation, autologous
Cyclophosphamide
Hodgkin disease
RC633-647.5
Antineoplastic Combined Chemotherapy Protocols/administration & Dosage
Źródło :
Revista Brasileira de Hematologia e Hemoterapia
Revista Brasileira de Hematologia e Hemoterapia, Volume: 33, Issue: 6, Pages: 432-438, Published: DEC 2011
Repositório Institucional da Unicamp
Revista Brasileira de Hematologia e Hemoterapia v.33 n.6 2011
Revista Brasileira de Hematologia e Hemoterapia, Vol 33, Iss 6, Pp 432-438 (2011)
Universidade Estadual de Campinas
Opis pliku :
text/html

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies